Endoscopy 2020; 52(S 01): S108
DOI: 10.1055/s-0040-1704332
ESGE Days 2020 oral presentations
Friday, April 24, 2020 17:00 – 18:30 Biliary diseases Liffey Hall 2
© Georg Thieme Verlag KG Stuttgart · New York

EUS-GUIDED HEPATICOGASTROSTOMY (HGS) AND ANTEGRADE TREATMENT WITH KAFFES ANASTOMOTIC STENT (KAS) OF BILIO-ENTERIC ANASTOMOTIC STRICTURES (BEAS) IN PATIENTS WITH SURGICALLY ALTERED ANATOMY (SAA)

C Chavarría
1   Hospital Universatorio Río Hortega, Gastroenterology, Valladolid, Spain
,
R Sánchez-Ocaña
1   Hospital Universatorio Río Hortega, Gastroenterology, Valladolid, Spain
,
J García-Alonso
1   Hospital Universatorio Río Hortega, Gastroenterology, Valladolid, Spain
,
C Alonso-Martín
1   Hospital Universatorio Río Hortega, Gastroenterology, Valladolid, Spain
,
AYC López
1   Hospital Universatorio Río Hortega, Gastroenterology, Valladolid, Spain
,
M de Benito-Sanz
1   Hospital Universatorio Río Hortega, Gastroenterology, Valladolid, Spain
,
J Tejedor-Tejada
1   Hospital Universatorio Río Hortega, Gastroenterology, Valladolid, Spain
,
C de la Serna-Higuera
1   Hospital Universatorio Río Hortega, Gastroenterology, Valladolid, Spain
,
M Perez-Miranda
1   Hospital Universatorio Río Hortega, Gastroenterology, Valladolid, Spain
› Author Affiliations
Further Information

Publication History

Publication Date:
23 April 2020 (online)

 
 

    Introduction BEAS can be treated endoscopically in SAA antegradely via HGS. We adapted KAS, originally designed for choledocho-choledochostomy strictures, to treat BEAS.

    Procedure Two stages: INDEX=a+b; a)Creation of HGS using transgastric cholangiography (segment-II), serial dilation, 8x80mm SEMS with antimigration flaps placement, stent dilation and fixation/clipping; b)Antegrade intervention attempting transanastomotic guidewire passage through catheters introduced via HGS, antegrade BEAS dilation, and transanastomotic KAS placement. REVISION=KAS&HGS removal. 5 BEAS were treated with 100% short-term success (1-cholangitis). At 21[3-33]-months follow-up, 4 patients finished treatment (3-asymptomatic/1-relapse, re-treated with KAS), and 1 await stent removal.

    Conclusions The design of KAS may enhance BEAS treatment via HGS.


    #